PTC
CLBT icon

Petrus Trust Company’s Cellebrite CLBT Stock Holding History

Petrus Trust Company’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-37,891
Closed -$606K – 235
2025
Q2 		$606K Buy
37,891
+18,328
+94% +$327K 0.06% 69
2025
Q1 		$380K Sell
19,563
-3,379
-15% -$71.1K 0.04% 306
2024
Q4 		$505K Sell
22,942
-30,633
-57% -$590K 0.05% 207
2024
Q3 		$902K Hold
53,575
– – 0.09% 50
2024
Q2 		$640K Buy
53,575
+7,100
+15% +$79.3K 0.06% 132
2024
Q1 		$515K Buy
+46,475
New +$474K 0.05% 197

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Petrus Trust Company's CLBT Position: Q3 2025 in Review

Petrus Trust Company sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 37,891 shares — an estimated $606K sold.

Petrus Trust Company first reported a position in CLBT in Q1 2024 and held it in 6 quarters. The position peaked at $902K in Q3 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Petrus Trust Company reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Petrus Trust Company sold 37,891 Cellebrite shares in Q3 2025, an estimated $606K.
  • Petrus Trust Company first reported a position in Cellebrite in Q1 2024 and held it in 6 quarters.
  • Petrus Trust Company's Cellebrite position peaked at $902K in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.